Should Patients Have a Say in Medical Device Regulatory Matters?

FDA has opened a docket to receive input from the public on a new priority list of patient preference-sensitive areas that may impact the design and conduct of premarket medical device clinical studies, benefit-risk assessments, and postmarket evaluation.